LectureRechercheRadarCadre d'investissement
Connexion / Inscription
← Retour à la lecture
ActualitésSujet · 英矽智能AI长寿药Prise rapide1 min de lectureRédaction DisconfirmAI

Insilico Medicine CEO Alex Zhavoronkov on AI in Longevity Therapeutics at ARDD 2026

Alex Zhavoronkov, CEO of Insilico Medicine, presented at ARDD 2026 on using AI to discover and develop longevity therapeutics credibly and equitably.

2026-10-09 21:02 GMT+8

This video resource features a presentation by Alex Zhavoronkov, CEO and Chief Business Officer of Insilico Medicine, at the ARDD 2026 conference. Zhavoronkov is a recognized figure in AI-driven drug discovery, leading a company focused on accelerating new drug development through artificial intelligence.

The talk is titled 'Longevity Therapeutics as the Most Impactful Trillion-Dollar Industry in Biotechnology: How to Discover and Develop Them in the Most Credible and Equitable Way with AI.' The topic centers on the potential of AI technology to address complex biomedical challenges, particularly in the frontier field of longevity.

For readers interested in the practical application of AI in biopharmaceuticals, this presentation offers a macro perspective from an industry leader on technical pathways and industrial prospects. Although a full transcript is not provided, the speaker's authority and the relevance of the topic make this resource worth selecting.

Sources

  • youtube.com↗
Sujet

英矽智能AI长寿药

美国生物技术公司英矽智能(Insilico Medicine)正试图通过生成式人工智能重塑长寿药物研发范式。该公司于2026年4月成立行业首个“长寿委员会”,由礼来高管担任主席,旨在打通前沿科学与大规模制药研发的壁垒。随后,英矽智能在9月发…

Connexion / Inscription
LectureRechercheRadarCadre d'investissement

5 étapes2 piècesMis à jour 2026-10-23 18:04

Comment on en est arrivé là

  1. 2026-04-21英矽智能宣布成立业界首个“长寿委员会”,由礼来分子发现集团副总裁Andrew Adams担任主席,Michael Levitt等科学家加入,旨在为AI赋能的衰老研究提供科学监督。prnasia.com ↗
  2. 2026-09-07《自然·生物技术》发表研究,显示英矽智能AI发现的药物Rentosertib在IIa期临床试验中降低了六种独立蛋白质组学衰老时钟的生物学年龄。insilico.com ↗
  3. 2026-09-17英矽智能联合团队在《细胞》杂志发表封面文章,推出LongevityBench、Longevity-LLMs和LongevityClaw组成的开源AI工具包,用于加速长寿研究。insilico.com ↗

Ce qui reste non résolu

  • FDA即将发布的监管科学优先领域文件将如何具体定义“衰老与长寿”的审批标准?
  • 英矽智能提出的“长寿疫苗”计划(基于环状mRNA和LNP)何时进入人体临床试验阶段?
  • 开源AI工具包LongevityBench能否被全球监管机构采纳为评估AI抗衰老药物的统一基准?

Également dans ce fil

  • Insilico Medicine Releases Short Documentary on Open-Source AI Longevity Toolkit2026-10-18
Lire le sujet complet →
Continuer la recherche →